Danaher Corporation (DHR) : Johnson Investment Counsel Inc reduced its stake in Danaher Corporation by 4.13% during the most recent quarter end. The investment management company now holds a total of 432,516 shares of Danaher Corporation which is valued at $35,202,477 after selling 18,610 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Danaher Corporation makes up approximately 1.11% of Johnson Investment Counsel Inc’s portfolio.
Other Hedge Funds, Including , Bradley Foster Sargent Incct reduced its stake in DHR by selling 2,125 shares or 0.52% in the most recent quarter. The Hedge Fund company now holds 402,991 shares of DHR which is valued at $32,755,108. Danaher Corporation makes up approx 1.43% of Bradley Foster Sargent Incct’s portfolio.Broderick Brian C boosted its stake in DHR in the latest quarter, The investment management firm added 10,501 additional shares and now holds a total of 25,656 shares of Danaher Corporation which is valued at $2,091,990. Danaher Corporation makes up approx 0.86% of Broderick Brian C’s portfolio.Whittier Trust Co Of Nevada Inc boosted its stake in DHR in the latest quarter, The investment management firm added 1,912 additional shares and now holds a total of 28,289 shares of Danaher Corporation which is valued at $2,303,856. Danaher Corporation makes up approx 0.25% of Whittier Trust Co Of Nevada Inc’s portfolio.Sumitomo Life Insurance Co reduced its stake in DHR by selling 980 shares or 3.4% in the most recent quarter. The Hedge Fund company now holds 27,846 shares of DHR which is valued at $2,253,855. Danaher Corporation makes up approx 0.30% of Sumitomo Life Insurance Co’s portfolio.
Danaher Corporation opened for trading at $81.16 and hit $81.33 on the upside on Tuesday, eventually ending the session at $81.03, with a gain of 0.12% or 0.1 points. The heightened volatility saw the trading volume jump to 22,05,013 shares. Company has a market cap of $55,954 M.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.